95 related articles for article (PubMed ID: 33629311)
1. The detection of SAS1B in serum provides clues for early diagnosis of thyroid cancer.
Yang HX; Yang Y; Li XD; Miao XM; Yang C; Zhi DF; Su H; Yang G; Gao J; Du CG; Li HJ; Song YL; Cao GF
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1410-1424. PubMed ID: 33629311
[TBL] [Abstract][Full Text] [Related]
2. Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
Pires ES; D'Souza RS; Needham MA; Herr AK; Jazaeri AA; Li H; Stoler MH; Anderson-Knapp KL; Thomas T; Mandal A; Gougeon A; Flickinger CJ; Bruns DE; Pollok BA; Herr JC
Oncotarget; 2015 Oct; 6(30):30194-211. PubMed ID: 26327203
[TBL] [Abstract][Full Text] [Related]
3. Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates.
Mandal A; Shetty J; Tran CA; Olson WC; Mandal M; Ban B; Pires ES; Adair SJ; Bauer TW; Slingluff CL; Herr JC
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485187
[TBL] [Abstract][Full Text] [Related]
4. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.
Knapp KA; Pires ES; Adair SJ; Mandal A; Mills AM; Olson WC; Slingluff CL; Parsons JT; Bauer TW; Bullock TN; Herr JC
Oncotarget; 2018 Feb; 9(10):8972-8984. PubMed ID: 29507667
[TBL] [Abstract][Full Text] [Related]
6. Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.
Melo-Hanchuk TD; Martins MB; Cunha LL; Soares FA; Ward LS; Vassallo J; Kobarg J
BMC Cancer; 2020 Jan; 20(1):23. PubMed ID: 31906878
[TBL] [Abstract][Full Text] [Related]
7. Correlations of ultrasound and pathological features of thyroid carcinoma with TC-1 mRNA and protein expression.
Zhang CL; Geng CH; Jian JJ; He M; Zhao HW; Li HY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3440-3446. PubMed ID: 31081098
[TBL] [Abstract][Full Text] [Related]
8. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
9. The role of TAK1 expression in thyroid cancer.
Lin P; Niu W; Peng C; Zhang Z; Niu J
Int J Clin Exp Pathol; 2015; 8(11):14449-56. PubMed ID: 26823762
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
11. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
12. Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma.
Tan B; Guo J; Wang L; Wang L; Gan X; Chen B
Exp Mol Pathol; 2021 Jun; 120():104643. PubMed ID: 33932399
[TBL] [Abstract][Full Text] [Related]
13. [Detection of galectin-3 in both serum and tissue for early diagnosis of thyroid carcinoma].
Xue G; Liu J; Huang J; Zhang J; Zhang W; Wu J; Shang X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1027-30. PubMed ID: 23895846
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
15. CD82, and CD63 in thyroid cancer.
Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
[TBL] [Abstract][Full Text] [Related]
16. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
17. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
18. LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.
Lu L; Yuan X; Zhang Q; Zhang H; Shen B
Mol Med Rep; 2017 Apr; 15(4):2015-2022. PubMed ID: 28260052
[TBL] [Abstract][Full Text] [Related]
19. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
[TBL] [Abstract][Full Text] [Related]
20. Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis.
Li X; Xu H; Ma H
Acta Chir Belg; 2013; 113(3):175-81. PubMed ID: 24941712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
